Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6V6L

Co-structure of human glycogen synthase kinase beta with 1-(6-((2-((6-amino-5-nitropyridin-2-yl)amino)ethyl)amino)-2-(2,4-dichlorophenyl)pyridin-3-yl)-4-methylpiperazin-2-one

6V6L の概要
エントリーDOI10.2210/pdb6v6l/pdb
分子名称Glycogen synthase kinase-3 beta, 1-(6-((2-((6-amino-5-nitropyridin-2-yl)amino)ethyl)amino)-2-(2,4-dichlorophenyl)pyridin-3-yl)-4-methylpiperazin-2-one, PHOSPHATE ION, ... (4 entities in total)
機能のキーワードkinase, transferase
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数1
化学式量合計47507.56
構造登録者
Bussiere, D.E.,Fang, E.,Shu, W. (登録日: 2019-12-05, 公開日: 2020-01-15, 最終更新日: 2024-11-20)
主引用文献Ramurthy, S.,Pfister, K.B.,Boyce, R.S.,Brown, S.P.,Costales, A.Q.,Desai, M.C.,Fang, E.,Levine, B.H.,Ng, S.C.,Nuss, J.M.,Ring, D.B.,Shafer, C.M.,Shu, W.,Subramanian, S.,Wagman, A.S.,Wang, H.,Bussiere, D.E.
Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitors.
Bioorg.Med.Chem.Lett., 30:126930-126930, 2020
Cited by
PubMed Abstract: Glycogen synthase kinase-3 plays an essential role in multiple biochemical pathways in the cell, particularly in regards to energy regulation. As such, Glycogen synthase kinase-3 is an attractive target for pharmacological intervention in a variety of disease states, particularly non-insulin dependent diabetes mellitus. However, due to homology with other crucial kinases, such as the cyclin-dependent protein kinase CDC2, developing compounds that are both potent and selective is challenging. A novel series of derivatives of 5-nitro-N2-(2-(pyridine-2ylamino)ethyl)pyridine-2,6-diamine were synthesized and have been shown to potently inhibit glycogen synthase kinase-3 (GSK3). Potency in the low nanomolar range was obtained along with remarkable selectivity. The compounds activate glycogen synthase in insulin receptor-expressing CHO-IR cells and in primary rat hepatocytes, and have acceptable pharmacokinetics and pharmacodynamics to allow for oral dosing. The X-ray co-crystal structure of human GSK3-β in complex with compound 2 is reported and provides insights into the structural determinants of the series responsible for its potency and selectivity.
PubMed: 31926786
DOI: 10.1016/j.bmcl.2019.126930
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.19 Å)
構造検証レポート
Validation report summary of 6v6l
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon